Drug
Deoxyglucose clinical trials
Also written 2-DG.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How studies write it
Studies that test it under each name
Name
Other names
- 2-DG
- 2
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2022 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 3
G.ST Antivirals GmbH (2) · University of Virginia (1) · Threshold Pharmaceuticals (1) · Rutgers, The State University of New Jersey (1) · University of Iowa (1)
Studies
Open first, then newest update. How each study uses Deoxyglucose is read from its arms, and is right about nine times in ten.
Testing it · 6
- Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of EpilepsyCompletedPhase 2University of VirginiaNCT05605301Written as Oral 2-Deoxy-D-Glucose (2DG)
- A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy AdultsTerminatedPhase 2G.ST Antivirals GmbHNCT06375772Written as 2-Deoxy-D-glucose
- A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate CancerTerminatedPhase 1/2Rutgers, The State University of New JerseyNCT00633087Written as 2-deoxyglucose
- Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy VolunteersCompletedPhase 1G.ST Antivirals GmbHNCT05314933Written as 2-Deoxyglucose
- Safety Study of 2DG With Stereotactic RadiosurgeryWithdrawnPhase 1University of IowaNCT00247403Written as 2-deoxyglucose (2DG)
- Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid TumorsCompletedPhase 1Threshold PharmaceuticalsNCT00096707Written as 2-deoxy-D-glucose (2DG)
Codes
What other systems call Deoxyglucose · ClinicalTrials.gg INT007313
- MeSH (NLM) D003847DeoxyglucoseConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 9G2MP84A8W2-DEOXYGLUCOSEConfirmed FDA, NLM
- RxNorm 1733674One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003847 | Deoxyglucose | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 9G2MP84A8W | 2-DEOXYGLUCOSE | Confirmed FDA, NLM |
| RxNorm | 1733674 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.